Construction and Validation of a Novel Eight-Gene Risk Score to Predict the Malignant Progression and Prognoses in Bladder Cancer Patients

Ruiliang Wang,Zongtai Zheng,Shiyu Mao,Wentao Zhang,Ji Liu,Cheng Li,Shenghua Liu,Xudong Yao

DOI: https://doi.org/10.21203/rs.3.rs-120263/v1

2020-01-01

Abstract:Abstract The progression from non-muscle-invasive bladder cancer (NMIBC) to muscle-invasive bladder cancer (MIBC) largely predisposes a life-threatening risk. Owing to this, it is of paramount importance to find new relevant molecular models that will allow for effectively predict the malignant progression of BC. Based on the RNA-Sequence data of 49 BC patients in our center and weighted gene co-expression network analysis methods, a co-expression network was developed using these genes before selecting the three key modules. Univariate Cox regression was used to select the key module genes with prognostic value in The Cancer Genome Atlas Program (TCGA). Subsequently, we developed an eight-gene risk score using the Least absolute shrinkage and selection operator Cox model. Notably, the eight-gene risk score was observed to be closely related to the malignant clinical features and also showed a favorable predictive power of differentiation between NMIBC and MIBC in the training (TCGA) and the two validation sets (GSE3289 and GSE13507). Furthermore, we generated a nomogram for predicting the overall survival. Both the calibrations and decision curve analysis curves displayed predictive effectiveness of the nomogram. Lastly, the RT-qPCR results revealed that the majority of the eight genes were differentially expressed between BC cell lines and a normal bladder epithelial cell line. Hence, from our study, we established a model of eight-gene risk score, with the potential of predicting malignant progression and determine prognoses of BC patients.